Post your job infront of 100,000+ qualified LP's and GP's.
Recently Filled Jobs
Firms you might be interested in
Posted on: Dec. 13, 2017, 10:31 a.m.
Venrock-backed Inscripta is taking an unusual business approach. : CRISPR gene editing is widely regarded as one of the most significant advances in the life sciences in decades. The technology, which allows scientists to slice and dice bits of genetic code with the help of special CRISPR enzymes, has implications in everything from curing devastating diseases to making pigs less fatty to creating bigger, tastier, genetically modified tomatoes. But existing CRISPR technologies are so red-hot that they’ve prompted an epic ... Full investment news articleRelevent to this post: MIT Investment Management Company Venrock,